Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03318367
Other study ID # 14D.354
Secondary ID
Status Terminated
Phase N/A
First received June 22, 2017
Last updated October 25, 2017
Start date August 6, 2014
Est. completion date August 11, 2016

Study information

Verified date October 2017
Source Thomas Jefferson University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies a virtual reality education module in reducing anxiety and increasing knowledge in patients with prostate cancer undergoing radiation therapy. A virtual reality education module may be useful in helping patients understand what they can expect to happen during their radiation treatments and help reduce stress relating to the radiation treatments.


Description:

PRIMARY OBJECTIVES:

I. To determine if a virtual reality education module for prostate cancer patients is effective in increasing patient comprehension and decreasing patient anxiety related to radiation treatments.

SECONDARY OBJECTIVES:

I. This pilot study could have implications for a broader patient base undergoing radiation therapy.


Recruitment information / eligibility

Status Terminated
Enrollment 23
Est. completion date August 11, 2016
Est. primary completion date June 3, 2016
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria:

- English speaking males capable of giving informed consent

- Must be able to read English language

- Receiving pre-treatment cone beam and volumetric modulated arc therapy (VMAT) for prostate cancer on the "A" or "B" treatment machines at the Bodine Center

- Must be able to walk two city blocks

- Must not have any auditory or visual deficits

Exclusion Criteria:

- If inclusion criteria are not met

- Previous radiation therapy treatment

- Employment in radiation oncology

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational Intervention
Complete virtual reality education module

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sidney Kimmel Cancer Center at Thomas Jefferson University

Outcome

Type Measure Description Time frame Safety issue
Primary Standard deviation for difference in questionnaire response from pre-education to post-education A one-sided one-sample t-test will be used to analyze the average change score (pre - post) for each questionnaire. Through study completion, an average of 2 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03197896 - Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods N/A
Completed NCT00026689 - Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Completed NCT00547625 - Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems Phase 2
Completed NCT00648323 - Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement Phase 4
Completed NCT00579423 - Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer Phase 2
Completed NCT00342433 - Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
Active, not recruiting NCT03047135 - Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis Phase 2
Enrolling by invitation NCT06364865 - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
Terminated NCT03197948 - Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
Completed NCT00586898 - Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle Phase 2
Recruiting NCT04518072 - Synthetic Metabolic and Genetic Networks for Medical Diagnosics
Completed NCT01118260 - Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection Phase 4
Recruiting NCT00923221 - Collection of Blood From Patients With Prostate Cancer
Active, not recruiting NCT01078662 - Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Phase 2
Completed NCT00423254 - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Phase 1
Terminated NCT02918227 - Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia N/A
Completed NCT05509114 - The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction N/A
Completed NCT02756975 - Prostate Core Needle Biopsy N/A
Active, not recruiting NCT00572468 - Statin Therapy Versus Placebo Prior to Prostatectomy N/A
Completed NCT00364455 - Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. Phase 3